id,drug1,object,drug2,precipitant,certainty,contraindication,dateAdded,ddiPkEffect,ddiPkMechanism,effectConcept,homepage,label,numericVal,objectUri,pathway,precaution,precipUri,severity,uri,whoAnnotated,source,ddiType,evidence,evidenceSource,evidenceStatement,researchStatementLabel,researchStatement,managementOptions
1,http://bio2rdf.org/drugbank:DB00897,TRIAZOLAM,http://bio2rdf.org/drugbank:DB00343,DILTIAZEM,None,None,"07/02/2007 17:38:07",http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/increases_auc,None,None,http://dbmi-icode-01.dbmi.pitt.edu/dikb-evidence/diltiazem_increases_auc_triazolam.html,"diltiazem increases the AUC of triazolam ",2.835,None,None,None,None,None,http://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIObservations1,boycer,DIKB,DDIObservation,http://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/39,http://www.ncbi.nlm.nih.gov/pubmed/8612379,"|Route of administration: oral|study duration: 1 day pretreatment with diltiazem given 3x/day @ 60mg PO. On day two .25mg triazolam was given PO|population: 10 subjects, male: 3 female: 7|ages: 18-31|AUC_i/AUC 0-time of measurement (17hrs): 36.0/12.7 = 2.835|AUC_i/AUC 0 -inf: 47/13.9 = 3.381|",diltiazem_increases_auc_triazolam,http://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Assertions/30,None
219,http://bio2rdf.org/drugbank:DB00897,triazolam,http://bio2rdf.org/drugbank:DB00343,diltiazem,None,None,None,None,None,None,None,"diltiazem is predicted to reduce the clearance of triazolam by inhibition of CYP3A4",None,None,http://purl.obolibrary.org/obo/PR_000006130,None,None,None,http://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/707,None,DIKB,DDIPrediction,None,None,None,None,None,None
23427,http://bio2rdf.org/drugbank:DB00897,Triazolam,http://bio2rdf.org/drugbank:DB00343,Diltiazem,None,None,None,None,None,None,None,"The calcium channel blocker, diltiazem, may increase the effect and toxicity of the benzodiazepine, triazolam.|",None,None,None,None,None,None,None,None,Drugbank,None,None,None,None,None,None,None
27011,http://bio2rdf.org/drugbank:DB00897,TRIAZOLAM,http://bio2rdf.org/drugbank:DB00343,Diltiazem,None,None,None,None,None,None,None,"DILTIAZEM/TRIAZOLAM [VA Drug Interaction]",None,None,None,None,None,Significant,http://purl.bioontology.org/ontology/NDFRT/N0000034907,None,NDF-RT,None,None,None,None,None,None,None
79559,http://bio2rdf.org/drugbank:DB00897,TRIAZOLAM,http://bio2rdf.org/drugbank:DB00343,DILTIAZEM,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,DDI-Corpus-2011,None,None,None,"The elimination half life of midazolam and triazolam also increased (1.5-2.5 fold) during coadministration with diltiazem.| ",None,None,None
81264,http://bio2rdf.org/drugbank:DB00897,TRIAZOLAM,http://bio2rdf.org/drugbank:DB00343,DILTIAZEM,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,DDI-Corpus-2013,mechanism,None,None,"The elimination half life of midazolam and triazolam also increased (1.5-2.5 fold) during coadministration with diltiazem.| ",None,None,None
81670,http://bio2rdf.org/drugbank:DB00897,TRIAZOLAM,http://bio2rdf.org/drugbank:DB00343,DILTIAZEM,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,NLM-Corpus,true,None,None,Increase_Interaction,None,None,None
89138,http://bio2rdf.org/drugbank:DB00897,Triazolam,http://bio2rdf.org/drugbank:DB00343,Diltiazem,None,None,None,None,None,N,None,None,None,None,None,None,None," ",None,None,OSCAR,None,P,None,,None,None,None
